2019
DOI: 10.1136/bmjhci-2019-100027
|View full text |Cite
|
Sign up to set email alerts
|

e-Therapies in England for stress, anxiety or depression: how are apps developed? A survey of NHS e-therapy developers

Abstract: ObjectiveTo document the quality of web and smartphone apps used and recommended for stress, anxiety or depression by examining the manner in which they were developed.DesignThe study was conducted using a survey sent to developers of National Health Service (NHS) e-therapies.Data sourcesData were collected via a survey sent out to NHS e-therapy developers during October 2015 and review of development company websites during October 2015.Data collection/extraction methodsData were compiled from responses to th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
14
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 14 publications
0
14
0
Order By: Relevance
“…“Technology push” also occurs when the commercial concerns of digital health care companies trump the wants/needs of patients and also challenges the values of clinicians [ 2 ]. The lack of sufficient depth of clinical and academic collaboration regarding electronic mental health innovation has been highlighted as a key feature of “technology push” [ 12 ]. The speed at which electronic mental health can be developed also threatens to ignore (or be ignorant of) robust methods for treatment development and associated evaluation [ 13 ].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…“Technology push” also occurs when the commercial concerns of digital health care companies trump the wants/needs of patients and also challenges the values of clinicians [ 2 ]. The lack of sufficient depth of clinical and academic collaboration regarding electronic mental health innovation has been highlighted as a key feature of “technology push” [ 12 ]. The speed at which electronic mental health can be developed also threatens to ignore (or be ignorant of) robust methods for treatment development and associated evaluation [ 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…The content of some electronic mental health apps has also been criticized for not being grounded in sufficient theory [ 14 ] and for the fact that the outcomes achieved during clinical trials are rarely replicated in routine service delivery settings [ 15 ]. Although a plethora of electronic mental health apps are readily available for the treatment of a variety of disorders and in a variety of contexts, questions can linger concerning a lack of evidence regarding feasibility, safety, clinical effectiveness, and efficacy [ 12 ]. The potential for technological innovations to outstrip the co-development of a sufficiently robust evidence base therefore risks a loss of confidence/trust from both clinicians and patients [ 16 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…"Technology push" also occurs when the commercial concerns of digital health care companies trump the wants/needs of patients and also challenges the values of clinicians [2]. The lack of sufficient depth of clinical and academic collaboration regarding electronic mental health innovation has been highlighted as a key feature of "technology push" [12]. The speed at which electronic mental health can be developed also threatens to ignore (or be ignorant of) robust methods for treatment development and associated evaluation [13].…”
Section: Introductionmentioning
confidence: 99%
“…The content of some electronic mental health apps has also been criticized for not being grounded in sufficient theory [14] and for the fact that the outcomes achieved during clinical trials are rarely replicated in routine service delivery settings [15]. Although a plethora of electronic mental health apps are readily available for the treatment of a variety of disorders and in a variety of contexts, questions can linger concerning a lack of evidence regarding feasibility, safety, clinical effectiveness, and efficacy [12]. The potential for technological innovations to outstrip the co-development of a sufficiently robust evidence base therefore risks a loss of confidence/trust from both clinicians and patients [16].…”
Section: Introductionmentioning
confidence: 99%